首页> 外文期刊>Post?py Higieny i Medycyny Do?wiadczalnej >SUMO-swoiste proteazy SENP jako potencjalne cele w terapii nowotworów
【24h】

SUMO-swoiste proteazy SENP jako potencjalne cele w terapii nowotworów

机译:SUMO特异性SENP蛋白酶可作为癌症治疗的潜在靶标

获取原文
       

摘要

Sumoylation is one of the post-translational modifications of proteins, responsible for the regulation of many cellular processes, such as DNA replication and repair, transcription, signal transduction and nuclear transport. During sumoylation, SUMO proteins are covalently attached to the ε-amino group of lysine in target proteins via an enzymatic cascade that requires the sequential action of E1, E2 and E3 enzymes. An important aspect of sumoylation is its reversibility, which involves SUMO-specific proteases called SENPs. SENPs (sentrin/SUMO-specific proteases) catalyze the deconjugation of SUMO proteins using their isopeptidase activity. These enzymes participate through hydrolase activity in the reaction of SUMO protein maturation, which involves the removal of a short fragment on the C-terminus of SUMO inactive form and exposure two glycine residues. SENPs are important for maintaining the balance between sumoylated and desumoylated proteins required for normal cellular physiology. Six SENP isoforms (SENP1, SENP2, SENP3, SENP5, SENP6 and SENP7) have been identified in mammals. These SENPs can be divided into three subfamilies based on their sequence homology, substrate specificity and subcellular localization. Results of studies indicate the role of SUMO proteases in the development of human diseases including cancer, suggesting that these proteins may be attractive targets for new drugs.
机译:糖基化是蛋白质翻译后的修饰之一,负责调节许多细胞过程,例如DNA复制和修复,转录,信号转导和核转运。在SUMO化过程中,SUMO蛋白通过需要E1,E2和E3酶的顺序作用的酶联级联共价连接到目标蛋白中赖氨酸的ε-氨基上。 sumoylation的一个重要方面是其可逆性,涉及SUMO特异性蛋白酶SENPs。 SENP(Sentrin / SUMO特异性蛋白酶)利用其异肽酶活性催化SUMO蛋白的去偶联。这些酶通过水解酶活性参与SUMO蛋白成熟的反应,这涉及去除SUMO非活性形式C末端的短片段并暴露两个甘氨酸残基。 SENP对于维持正常细胞生理所需的磺酰化和去磺酰化蛋白之间的平衡很重要。在哺乳动物中已鉴定出六种SENP亚型(SENP1,SENP2,SENP3,SENP5,SENP6和SENP7)。这些SENP可以根据其序列同源性,底物特异性和亚细胞定位分为三个亚家族。研究结果表明,SUMO蛋白酶在人类疾病(包括癌症)发展中的作用,表明这些蛋白质可能是新药的诱人靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号